Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22884505

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2012 Sep
First author
Ismael G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Sep;13(9):850-1. doi: 10.1016/S1470-2045(12)70367-4.
    note
    Source null
    related pmid
    22884504
    relationship
    Comment in

Authors and identifiers

  1. name
    Ismael G
    type
    Author
  2. name
    Hegg R
    type
    Author
  3. name
    Muehlbauer S
    type
    Author
  4. name
    Heinzmann D
    type
    Author
  5. name
    Lum B
    type
    Author
  6. name
    Kim SB
    type
    Author
  7. name
    Pienkowski T
    type
    Author
  8. name
    Lichinitser M
    type
    Author
  9. name
    Semiglazov V
    type
    Author
  10. name
    Melichar B
    type
    Author
  11. name
    Jackisch C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ismael G
    type
    Author
  2. name
    Hegg R
    type
    Author
  3. name
    Muehlbauer S
    type
    Author
  4. name
    Heinzmann D
    type
    Author
  5. name
    Lum B
    type
    Author
  6. name
    Kim SB
    type
    Author
  7. name
    Pienkowski T
    type
    Author
  8. name
    Lichinitser M
    type
    Author
  9. name
    Semiglazov V
    type
    Author
  10. name
    Melichar B
    type
    Author
  11. name
    Jackisch C
    type
    Author
bibliography ids
  1. nci-bib-4b2547b9789f823b30804e83
book metadata
content sha256
bebaa7dc834ed3652603ed188c75fabf39ba93f767269fb5b6f36e3ba7c5f828
document type
citation
dois
  1. 10.1016/S1470-2045(12)70329-7
electronic publication date
display
2012 Aug 9
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22884505
immutable id
pubmed:22884505@bebaa7dc834ed3652603ed188c75fabf39ba93f767269fb5b6f36e3ba7c5f828
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
869-78
volume
13
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Sep;13(9):850-1. doi: 10.1016/S1470-2045(12)70367-4.
    note
    Source null
    related pmid
    22884504
    relationship
    Comment in
outcomes validated
false
pmid
22884505
provenance
batch id
1e3045de9f47a5ccd566
provider
NCBI PubMed ESummary
record sha256
2af2176920fdbfc4dbdb4ea8fd8e8c24b74b1c495268d2bb6788e5f75324aeaf
response sha256
0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
retrieved at
2026-09-09T23:46:50.128287+00:00
publication date
display
2012 Sep
precision
month
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22884505/
title
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial.

Preserved source evidence · Not medical advice